Keyphrases
COVID-19
100%
Intervention Evaluation
94%
Europe
88%
Infection Prevention
77%
Hospitalized Patients
72%
Transmission Dynamics
66%
Clostridium Difficile Infection
66%
Hospital Transmission
66%
Mathematical Model
66%
Contact Matrix
66%
Modeling Analysis
66%
Intervention Modeling
66%
Systems-based Approach
66%
Antimicrobial Therapy
66%
Time-use Data
66%
Disease Dynamics
66%
Therapy Resistance
66%
Antimicrobial Resistance
66%
Respiratory Infection
66%
Primary Care
66%
Antibiotic Prescribing
66%
Unintended Consequences
66%
Impedance Flow Cytometry
66%
Urinary Tract Infection
66%
Cost-effectiveness Analysis
66%
Rapid Antimicrobial Susceptibility Testing
66%
Secondary Care
66%
Economic Evaluation
66%
Adult Hospital
66%
Umbrella Review
66%
Healthcare-associated Infections
66%
Daily Activities
50%
Healthcare Workers
50%
Health Systems
38%
Nosocomial Transmission
33%
Suspected COVID-19
33%
Public Health Interventions
33%
Uncomplicated UTI
33%
Quality-adjusted Life Years
33%
National Health Service
33%
Net Monetary Benefit
33%
Cost-effectiveness
33%
Adjusted Odds Ratio
28%
Infection-related
28%
Reconsultation
28%
Antimicrobial Use
23%
Dynamic Transmission Model
22%
Resistance Prevalence
22%
Systems Perspective
22%
Young Female
22%
Nursing and Health Professions
Prevention and Control
66%
Control Strategy
66%
Infection
66%
Health Care Personnel
66%
Antimicrobial Therapy
66%
Infection Control
66%
Infection Prevention
66%
Antimicrobial Resistance
66%
Respiratory Tract Infection
66%
Primary Medical Care
66%
Urinary Tract Infection
66%
Secondary Health Care
66%
Cost Effectiveness Analysis
66%
Therapy Resistance
66%
Cytometry
57%
Severe Acute Respiratory Syndrome
44%
Odds Ratio
28%
Socialized Medicine
28%
Healthcare System
28%
Quality Adjusted Life Year
28%
Hospital Infection
22%
Pandemic Response
22%
Prevalence
19%
Antiinfective Agent
14%
Gram Positive Infection
11%
Adverse Outcome
9%
Adverse Event
9%
Clinical Practice
9%
General Practice
9%
General Practitioner
9%
Case Mix
9%
Hospital Inpatient
9%
Inappropriate Prescribing
9%
Clinical Outcome
5%
Medicine and Dentistry
Public Health
66%
Primary Health Care
66%
COVID-19
66%
Respiratory Tract Infection
66%
Antimicrobial Therapy
66%
Antibiotic Resistance
66%
Secondary Care
66%
Antibiogram
66%
Urinary Tract Infection
66%
Cost-Effectiveness Analysis
66%
Therapy Resistance
66%
Diseases
66%
Cytometry
57%
Pathogen
38%
Health Care Cost
38%
Social Distancing
33%
Infection
33%
Leisure Activity
33%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Odds Ratio
28%
Quality Adjusted Life Year
28%
National Health Service
28%
Prevalence
19%
Adverse Outcome
9%
General Practitioner
9%
General Medicine
9%
Case Mix
9%
Adverse Event
9%
Hospital Inpatient
9%
Inappropriate Prescribing
9%
Antiinfective Agent
5%
Health System
5%
Population Health
5%
